PGEN PE Ratio & Valuation,Is PGEN Overvalued

PGEN Relative Valuation

PGEN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PGEN is overvalued; if below, it's undervalued.

Historical Valuation

Precigen Inc (PGEN) is now in the Undervalued zone, suggesting that its current forward PS ratio of 14.56 is considered Undervalued compared with the five-year average of -6.08. The fair price of Precigen Inc (PGEN) is between 1194.36 to 1207.91 according to relative valuation methord. Compared to the current price of 3.69 USD , Precigen Inc is Undervalued By 99.69%.

Relative Value

Fair Zone

1194.36-1207.91

Current Price：3.69

99.69%

Undervalued

-15.50

0.00

EV/EBITDA

Precigen Inc. (PGEN) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is -0.89. The thresholds are as follows: Strongly Undervalued below -9.53, Undervalued between -9.53 and -5.21, Fairly Valued between 3.43 and -5.21, Overvalued between 3.43 and 7.75, and Strongly Overvalued above 7.75. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.

-18.99

EV/EBIT

Precigen Inc. (PGEN) has a current EV/EBIT of -18.99. The 5-year average EV/EBIT is -7.66. The thresholds are as follows: Strongly Undervalued below -19.99, Undervalued between -19.99 and -13.83, Fairly Valued between -1.50 and -13.83, Overvalued between -1.50 and 4.67, and Strongly Overvalued above 4.67. The current Forward EV/EBIT of -18.99 falls within the Undervalued range.

14.56

Precigen Inc. (PGEN) has a current PS of 14.56. The 5-year average PS is 34.37. The thresholds are as follows: Strongly Undervalued below -32.46, Undervalued between -32.46 and 0.96, Fairly Valued between 67.78 and 0.96, Overvalued between 67.78 and 101.19, and Strongly Overvalued above 101.19. The current Forward PS of 14.56 falls within the Historic Trend Line -Fairly Valued range.

-8.38

P/OCF

Precigen Inc. (PGEN) has a current P/OCF of -8.38. The 5-year average P/OCF is -8.25. The thresholds are as follows: Strongly Undervalued below -18.41, Undervalued between -18.41 and -13.33, Fairly Valued between -3.17 and -13.33, Overvalued between -3.17 and 1.91, and Strongly Overvalued above 1.91. The current Forward P/OCF of -8.38 falls within the Historic Trend Line -Fairly Valued range.

-7.69

P/FCF

Precigen Inc. (PGEN) has a current P/FCF of -7.69. The 5-year average P/FCF is -7.07. The thresholds are as follows: Strongly Undervalued below -18.96, Undervalued between -18.96 and -13.02, Fairly Valued between -1.13 and -13.02, Overvalued between -1.13 and 4.81, and Strongly Overvalued above 4.81. The current Forward P/FCF of -7.69 falls within the Historic Trend Line -Fairly Valued range.

Precigen Inc (PGEN) has a current Price-to-Book (P/B) ratio of 31.31. Compared to its 3-year average P/B ratio of 1.97 , the current P/B ratio is approximately 1486.06% higher. Relative to its 5-year average P/B ratio of 4.71, the current P/B ratio is about 564.67% higher. Precigen Inc (PGEN) has a Forward Free Cash Flow (FCF) yield of approximately -5.79%. Compared to its 3-year average FCF yield of -19.90%, the current FCF yield is approximately -70.90% lower. Relative to its 5-year average FCF yield of -16.41% , the current FCF yield is about -64.71% lower.

31.31

P/B

Median3y

1.97

Median5y

4.71

-5.79

FCF Yield

Median3y

-19.90

Median5y

-16.41

Competitors Valuation Multiple

The average P/S ratio for PGEN's competitors is 7.08, providing a benchmark for relative valuation. Precigen Inc Corp (PGEN) exhibits a P/S ratio of 14.56, which is 105.56% above the industry average. Given its robust revenue growth of 206.61%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of PGEN increased by 229.46% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 953.00K to 2.92M.

The secondary factor is the Margin Expansion, contributed 99.06%to the performance.

Overall, the performance of PGEN in the past 1 year is driven by Revenue Growth. Which is more sustainable.

206.61%

953.00K → 2.92M

Revenue Growth

99.06%

-2.52K → -5.01K

Margin Expansion

-76.21%

-10.89 → -2.59

P/E Change

229.46%

1.12 → 3.69

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is Precigen Inc (PGEN) currently overvalued or undervalued?

What is Precigen Inc (PGEN) fair value?

PGEN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Precigen Inc (PGEN) is between 1194.36 to 1207.91 according to relative valuation methord.

How does PGEN's valuation metrics compare to the industry average?

What is the current P/B ratio for Precigen Inc (PGEN) as of Dec 15 2025?

As of Dec 15 2025, Precigen Inc (PGEN) has a P/B ratio of 31.31. This indicates that the market values PGEN at 31.31 times its book value.

What is the current FCF Yield for Precigen Inc (PGEN) as of Dec 15 2025?

As of Dec 15 2025, Precigen Inc (PGEN) has a FCF Yield of -5.79%. This means that for every dollar of Precigen Inc’s market capitalization, the company generates -5.79 cents in free cash flow.

What is the current Forward P/E ratio for Precigen Inc (PGEN) as of Dec 15 2025?

As of Dec 15 2025, Precigen Inc (PGEN) has a Forward P/E ratio of -15.50. This means the market is willing to pay $-15.50 for every dollar of Precigen Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Precigen Inc (PGEN) as of Dec 15 2025?

As of Dec 15 2025, Precigen Inc (PGEN) has a Forward P/S ratio of 14.56. This means the market is valuing PGEN at $14.56 for every dollar of expected revenue over the next 12 months.

PGEN Valuation